Exponent Inc
NASDAQ:EXPO
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
74.81
115.28
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Exponent Inc
Wall Street
Price Targets
EXPO Price Targets Summary
Exponent Inc
According to Wall Street analysts, the average 1-year price target for
EXPO
is 118.32 USD
with a low forecast of 113.12 USD and a high forecast of 126 USD.
EXPO Last Price Targets
Exponent Inc
The latest public price target was made on Jul 26, 2024 by
Tobey Sommer
from
Truist Financial
,
who expects
EXPO
stock to
rise by 33%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Tobey Sommer
Truist Financial
|
120
USD
Upside 33% |
4 months ago
Jul 26, 2024
|
Exponent price target raised to $120 from $100 at Truist
TheFly
|
Joshua Chan
UBS
|
88
USD
Downside 3% |
5 months ago
Jun 26, 2024
|
UBS Reiterates Neutral Rating on Exponent (EXPO)
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is EXPO's stock price target?
Price Target
118.32
USD
According to Wall Street analysts, the average 1-year price target for
EXPO
is 118.32 USD
with a low forecast of 113.12 USD and a high forecast of 126 USD.
What is Exponent Inc's Revenue forecast?
Projected CAGR
3%
For the last 8 years the
compound annual growth rate for
Exponent Inc's revenue is
7%.
The projected
CAGR
for the next 3 years is
3%.
What is Exponent Inc's Operating Income forecast?
Projected CAGR
11%
For the last 8 years the
compound annual growth rate for
Exponent Inc's operating income is
6%.
The projected
CAGR
for the next 3 years is
11%.
What is Exponent Inc's Net Income forecast?
Projected CAGR
5%
For the last 8 years the
compound annual growth rate for
Exponent Inc's net income is
11%.
The projected
CAGR
for the next 3 years is
5%.
You don't have any saved screeners yet
